Phase III trial of AD 04 (ultra-low dose ondansetron) for alcohol use disorder (first phase III trial).

Trial Profile

Phase III trial of AD 04 (ultra-low dose ondansetron) for alcohol use disorder (first phase III trial).

Planning
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Alcoholism
  • Focus Registrational; Therapeutic Use
  • Sponsors ADial Pharmaceuticals
  • Most Recent Events

    • 01 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top